Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CAH✓SelectedUSD · CAHMRNA vs CAH performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs CAH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
CAH return
+176.7%
Excess return
-29.8%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioCAHExcessAlpha
1D-2.2%+0.2%-2.3%-2.2%
7D-12.7%-2.9%-9.8%-12.1%
30D-20.7%+6.0%-26.6%-21.7%
3M+46.3%+19.7%+26.6%+41.1%
6M+305.2%+37.5%+267.7%+281.1%
YTD+561.2%+34.0%+527.2%+522.1%
1Y+772.1%+32.5%+739.6%+723.0%
3Y+147.0%+170.5%-23.6%+108.1%
All+147.0%+176.7%-29.8%+108.1%

Cumulative growth

Daily Returns

Daily percentage return beside CAH.

Daily Out/Under-Performance

Portfolio return minus CAH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CAH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded CAH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling